Requires pediatric care providers to screen every child beginning at the age of twelve months for autism spectrum disorders

• Democratic5

◆ The sponsor's argument

Why Kevin S. Parker says this is needed

Autism Spectrum Disorders (ASD) affect millions worldwide, impacting individuals' social interactions, communication skills, and behavior. Early detection and intervention significantly improve outcomes, yet many cases remain undiagnosed until later stages. This delay hinders timely interventions critical for enhancing quality of life. Hence, legislating screening for ASD at wellness and preventative care visits is imperative to ensure early identification and intervention. Research consistently demonstrates the benefits of early intervention for ASD. Interventions initiated before three years of age significantly improve cognitive, language, and adaptive functioning, enhancing longterm prog- nosis. By screening at twelve months and subsequent pivotal stages, we maximize the window for early intervention, optimizing developmental trajectories. Despite advancements, many children with ASD remain undi- agnosed until later ages, missing crucial intervention opportunities. By incorporating ASD screening into routine wellness visits, we identify cases earlier, reducing the burden on families, healthcare systems, and society. Early detection empowers families to access support services promptly, fostering better outcomes for affected individuals. The Centers for Disease Control and Prevention -(CDC) recommends ASD screen- ing at 9, 18, and 30 months, underscoring the importance of early detection. However, this guidance often gets overlooked or inconsistent- ly implemented. Legislative action standardizes screening protocols, ensuring universal access and adherence to evidence-based practices, aligning with public health goals of early intervention and improved outcomes. Early detection and intervention not only improve individual outcomes but also yield substantial cost savings over the lifespan. By investing in early screening, we mitigate long-term healthcare, educational, and societal costs associated with untreated ASD. Proactive measures such as legislative mandates for screening represent prudent investments in public health, maximizing resource utilization and societal well-being. ASD prevalence is consistent across diverse populations, yet disparities exist in access to early screening and intervention services. Legis- lation mandating screening at wellness visits ensures equitable access to diagnostic resources, irrespective of socioeconomic status, geograph- ic location, or healthcare provider. By prioritizing early detection as a standard of care, we promote health equity and address systemic barri- ers to timely ASD diagnosis and intervention. Legislating screening for ASD at wellness and preventative care visits, starting at twelve months of age and subsequently at key developmental stages, is a proactive step towards improving outcomes for individuals with ASD. By aligning with CDC recommendations, evidence-based practice, and principles of equity and cost-effectiveness, such legislation prior- itizes early intervention, resource optimization, and health equity. Together, we can enhance the well-being and potential of individuals with ASD, fostering a more inclusive and supportive society.

This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.